Your session is about to expire
← Back to Search
Non-App User Study Participant for Colorectal Surgery
N/A
Waitlist Available
Led By Malcolm H Squires, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days following hospital discharge
Awards & highlights
Summary
The purpose of this study is to evaluate whether patient-centered educational material delivered before and immediately after surgery can help improve outcomes for patients undergoing colorectal surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days following hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days following hospital discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
30-day readmission
Perioperative ERAS metric completion rate
Postoperative complications
+1 moreSecondary study objectives
Postoperative Opioid Consumption
Trial Design
2Treatment groups
Experimental Treatment
Group I: SeamlessMD Mobile ApplicationExperimental Treatment1 Intervention
Participants enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation over 30 days. Participants will also be prompted by the app to record their daily narcotic consumption via an "Opioid Tracker" page that requests participants enter the number of doses taken for each narcotic medication in the last 24 hours.
Group II: Non-App User Study ParticipantExperimental Treatment0 Interventions
Participants will receive on postoperative day one (POD1) in the hospital a one-page paper survey of the same questions prompted by the SeamlessMD app regarding completion of preoperative ERAS metrics.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SeamlessMD® Mobile Application
2021
N/A
~80
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,632 Total Patients Enrolled
Atrium Health Levine Cancer InstituteOTHER
24 Previous Clinical Trials
1,764 Total Patients Enrolled
Malcolm H Squires, MDPrincipal InvestigatorWake Forest University Health Sciences
Share this study with friends
Copy Link
Messenger